Last news
Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma

Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma

HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in...

A Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia

A Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia

PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ -- In a landmark move to safeguard the vision of Malaysia's future generation, VISTA Eye Specialist ('VISTA'), the nation's trusted eye care brand, announced a strategic collaboration Memorandum...

Global Media Witnesses Chery Super Hybrid (CSH)'s Breakthrough as 'Endless Horizon Worry-Free Voyage' Endurance Challenge Completes First Stage

Global Media Witnesses Chery Super Hybrid (CSH)'s Breakthrough as 'Endless Horizon Worry-Free Voyage' Endurance Challenge Completes First Stage

SHANGHAI, April 25, 2025 /PRNewswire/ -- On April 23, coinciding with the opening day of 2025 Shanghai Auto Show, the first stage of Chery Super Hybrid (CSH) "Endless Horizon Worry-Free Voyage" endurance challenge successfully concluded. This...

ZERO BREEZE Partners with NASCAR Driver Patrick Emerling to Bring Cooling Innovation to the Track

ZERO BREEZE Partners with NASCAR Driver Patrick Emerling to Bring Cooling Innovation to the Track

LINCOLN, Ala., April 25, 2025 /PRNewswire/ -- ZERO BREEZE, a leader in portable air conditioning technology, is thrilled to announce its official partnership with Patrick Emerling, the accomplished NASCAR Xfinity Series driver. Both ZERO BREEZE and...

Theo Raises $20M to Democratize Access to Institutional-Grade Trading Infrastructure

Theo Raises $20M to Democratize Access to Institutional-Grade Trading Infrastructure

Founded by ex-Optiver and IMC quants, the platform is backed by angels from Citadel, Jane Street, and JPMorgan NEW YORK, April 25, 2025 /PRNewswire/ -- Theo, a novel network connecting onchain capital to global markets via institutional-grade...

Atomicwork launches its Universal Agent, bringing Multimodal AI to every employee's flow of work

Atomicwork launches its Universal Agent, bringing Multimodal AI to every employee's flow of work

This first-of-its-kind Universal Agent eliminates manual work with Voice and Vision AI to make end-users and IT teams 10x more productive SAN FRANCISCO, April 25, 2025 /PRNewswire/ -- Atomicwork today launched its Universal Agent, a new multimodal...

Lionsgate's 'Now You See Me: Now You Don't' Brings Some of Its Movie Magic to Abu Dhabi in Collaboration with Abu Dhabi's Creative Media Authority, Abu Dhabi Film Commission and Miral Destinations

Lionsgate's 'Now You See Me: Now You Don't' Brings Some of Its Movie Magic to Abu Dhabi in Collaboration with Abu Dhabi's Creative Media Authority, Abu Dhabi Film Commission and Miral Destinations

ABU DHABI, UAE, April 25, 2025 /PRNewswire/ -- Abu Dhabi residents might have captured an exciting glimpse of several scenes from Lionsgate's highly anticipated movie Now You See Me: Now You Don't, which wrapped an action-packed 13-day shoot across...

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis

VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU Clinically meaningful...

menu
menu